DNAJC30 defect: a frequent cause of recessive Leber hereditary optic neuropathy and Leigh syndrome.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
03 06 2022
Historique:
received: 18 10 2021
revised: 17 12 2021
accepted: 05 01 2022
pubmed: 12 2 2022
medline: 9 6 2022
entrez: 11 2 2022
Statut: ppublish

Résumé

The recent description of biallelic DNAJC30 variants in Leber hereditary optic neuropathy (LHON) and Leigh syndrome challenged the longstanding assumption for LHON to be exclusively maternally inherited and broadened the genetic spectrum of Leigh syndrome, the most frequent paediatric mitochondrial disease. Herein, we characterize 28 so far unreported individuals from 26 families carrying a homozygous DNAJC30 p.Tyr51Cys founder variant, 24 manifesting with LHON, two manifesting with Leigh syndrome, and two remaining asymptomatic. This collection of unreported variant carriers confirms sex-dependent incomplete penetrance of the homozygous variant given a significant male predominance of disease and the report of asymptomatic homozygous variant carriers. The autosomal recessive LHON patients demonstrate an earlier age of disease onset and a higher rate of idebenone-treated and spontaneous recovery of vision in comparison to reported figures for maternally inherited disease. Moreover, the report of two additional patients with childhood- or adult-onset Leigh syndrome further evidences the association of DNAJC30 with Leigh syndrome, previously only reported in a single childhood-onset case.

Identifiants

pubmed: 35148383
pii: 6527177
doi: 10.1093/brain/awac052
pmc: PMC9166554
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1624-1631

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

Genes (Basel). 2021 Apr 02;12(4):
pubmed: 33918393
Ann Neurol. 2003 Jan;53(1):128-32
pubmed: 12509858
J Neuroophthalmol. 2000 Sep;20(3):166-70
pubmed: 11001192
Ann Neurol. 2022 Jan;91(1):117-130
pubmed: 34716721
Cell. 2018 Nov 1;175(4):1088-1104.e23
pubmed: 30318146
J Neuroophthalmol. 2020 Dec;40(4):547-557
pubmed: 32969847
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5303-9
pubmed: 17122117
J Med Genet. 2018 Jan;55(1):21-27
pubmed: 29101127
Nat Rev Neurol. 2012 Oct;8(10):545-56
pubmed: 22945544
Am J Hum Genet. 1996 Aug;59(2):481-5
pubmed: 8755941
J Inherit Metab Dis. 2020 Jul;43(4):819-826
pubmed: 31967322
Brain. 2009 Apr;132(Pt 4):833-42
pubmed: 19336460
Orphanet J Rare Dis. 2021 Oct 9;16(1):413
pubmed: 34627336
Brain. 2011 Sep;134(Pt 9):e188
pubmed: 21810891
Am J Hum Genet. 2003 Feb;72(2):333-9
pubmed: 12518276
J Neuroophthalmol. 2017 Dec;37(4):371-381
pubmed: 28991104
Mol Genet Metab. 2011 Jun;103(2):153-60
pubmed: 21414825
Clin Genet. 2020 Apr;97(4):586-594
pubmed: 32020600
Acta Neuropathol. 2016 Dec;132(6):789-806
pubmed: 27696015
Brain. 2011 Sep;134(Pt 9):2677-86
pubmed: 21788663
Prog Retin Eye Res. 2011 Mar;30(2):81-114
pubmed: 21112411
J Clin Invest. 2021 Mar 15;131(6):
pubmed: 33465056
J Med Genet. 2017 May;54(5):346-356
pubmed: 28031252
J Neuropathol Exp Neurol. 2015 Jun;74(6):482-92
pubmed: 25978847
eNeurologicalSci. 2019 Jan 11;14:74-76
pubmed: 30705974
J Neuroophthalmol. 2020 Dec;40(4):558-565
pubmed: 32991388
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1370-5
pubmed: 27007794
Eye (Lond). 2014 May;28(5):521-37
pubmed: 24603424

Auteurs

Sarah L Stenton (SL)

Institute of Human Genetics, School of Medicine, Technische Universität München, München, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, München, Germany.

Marketa Tesarova (M)

Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Natalia L Sheremet (NL)

Federal State Budgetary Institution of Science 'Research Institute of Eye Diseases', Moscow, Russia.

Claudia B Catarino (CB)

Department of Neurology, Friedrich-Baur-Institute, University Hospital of the Ludwig-Maximilians-Universität München, Munich, Germany.

Valerio Carelli (V)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogentica, Bologna, Italy.
Unit of Neurology, Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Italy.

Elżbieta Ciara (E)

Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.

Kathryn Curry (K)

Genetics and Metabolic Clinic, St. Luke's Health System, Boise, USA.

Martin Engvall (M)

Centre for Inherited Metabolic Diseases (CMMS), Karolinska University Hospital, Stockholm, Sweden.

Leah R Fleming (LR)

Genetics and Metabolic Clinic, St. Luke's Health System, Boise, USA.

Peter Freisinger (P)

Department of Paediatrics, Metabolic Disease Center, Klinikum Reutlingen, Reutlingen, Germany.

Katarzyna Iwanicka-Pronicka (K)

Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.
Department of Audiology and Phoniatrics, The Children's Memorial Health Institute, Warsaw, Poland.

Elżbieta Jurkiewicz (E)

Department of Diagnostic Imaging, The Children's Memorial Health Institute, Warsaw, Poland.

Thomas Klopstock (T)

Department of Neurology, Friedrich-Baur-Institute, University Hospital of the Ludwig-Maximilians-Universität München, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.

Mary K Koenig (MK)

Center for the Treatment of Pediatric Neurodegenerative Disease, The University of Texas McGovern Medical School at Houston, Houston, USA.

Hana Kolářová (H)

Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Bohdan Kousal (B)

Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Tatiana Krylova (T)

Research Centre for Medical Genetics, Moscow, Russia.

Chiara La Morgia (C)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogentica, Bologna, Italy.

Lenka Nosková (L)

Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Dorota Piekutowska-Abramczuk (D)

Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.

Sam N Russo (SN)

Center for the Treatment of Pediatric Neurodegenerative Disease, The University of Texas McGovern Medical School at Houston, Houston, USA.

Viktor Stránecký (V)

Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Iveta Tóthová (I)

Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Frank Träisk (F)

Department of Neuro-Ophthalmology, St Erik Eye Hospital, Stockholm, Sweden.

Holger Prokisch (H)

Institute of Human Genetics, School of Medicine, Technische Universität München, München, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, München, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH